Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Core Insights - Aesthetic Record has been selected as a key partner for Obagi Medical's ALOHA Program, focusing on the integration of technology and real-world data to enhance aesthetic practices across the U.S. [1][4] Company Overview - Obagi Medical is recognized as a leading innovator in physician-dispensed skincare, with over 35 years of experience and a focus on addressing various skin concerns [6]. - Aesthetic Record is the leading Electronic Medical Records (EMR) and Practice Management platform specifically designed for the medical aesthetics industry, serving thousands of practices [7][8]. Partnership Details - The partnership aims to leverage Aesthetic Record's technology to capture real-world data, enhancing the launch of Obagi's new injectable, saypha MagIQ™ [2][4]. - The ALOHA Real-World Program will provide Aesthetic Record users with hands-on experience with Obagi products, aiming to improve patient satisfaction and provider relationships [2][3]. Technology and Innovation - Obagi's saypha MagIQ™ utilizes proprietary MACRO Core Technology to create a stable hyaluronic acid matrix, designed for natural-looking results and high performance [4]. - Aesthetic Record's platform offers integrated tools for efficient charting, compliance monitoring, and performance tracking, which are essential for high-volume aesthetic practices [2][8]. Industry Impact - Initial findings from the partnership will be presented at the Aesthetic Next conference, showcasing the benefits of the new protocols and products within the Aesthetic Record ecosystem [3]. - The collaboration is positioned to advance the aesthetics industry by combining innovative injectables with streamlined technology, ultimately aiming for better patient outcomes [2].